Home > Insider Trading > Filing (0001437749-20-012378)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
834365	Biolife Solutions Inc	BLFS	Electromedical & Electrotherapeutic Apparatus (3845)	943076866

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1273547	Thomas Girschweiler	C/O Biolife Solutions, Inc. 3303 Monte Villa Parkway, Suite 310 Bothell WA 98021		Yes	No	Yes	No
1603397	Gmbh Taurus4757	Roosstrasse 53 Ch-8832 Wollerau Zurich V8 CH-8057		No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2019-01-17	10,714	$1.26	1,535,391	No	4	M	Indirect	By Taurus4757 GmbH
Common Stock	Disposition	2019-10-04	162,760	$15.36	1,372,631	No	4	S	Indirect	By Taurus4757 GmbH
Common Stock	Acquisiton	2020-05-13	1,544,194	$4.75	2,916,825	No	4	X	Indirect	By Taurus4757 GmbH
Common Stock	Disposition	2020-05-13	492,277	$14.90	2,424,548	No	4	S	Indirect	By Taurus4757 GmbH
Common Stock	Disposition	2020-05-22	476,191	$10.50	1,948,357	No	4	S	Indirect	By Taurus4757 GmbH

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Indirect	By Taurus4757 GmbH
No	4	S	Indirect	By Taurus4757 GmbH
No	4	X	Indirect	By Taurus4757 GmbH
No	4	S	Indirect	By Taurus4757 GmbH
No	4	S	Indirect	By Taurus4757 GmbH

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2019-01-17	10,714	$0.00	10,714	$1.26
Common Stock	Warrants (Right to Buy)	Disposition	2020-05-13	1,544,194	$0.00	1,544,194	$4.75

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2010-02-27	2019-02-26	No	4	M	Direct
0	2014-03-25	2021-03-25	No	4	X	Indirect

Footnotes

The shares of common stock, par value $0.001 per share (the "Common Stock") were issued to Taurus457 GmbH ("Taurus"), an entity wholly owned by Thomas Girschweiler (together with Taurus, the "reporting person") a director and 10% shareholder of Biolife Solutions, Inc. (the "Company"), upon exercise of the warrants held by the reporting person.
On May 13, 2020, the reporting person exercised an in-the-money warrant to purchase 1,544,194 shares of Common Stock of the Company for $4.75 per share pursuant to Rule 16b-6 under the Securities Exchange Act of 1934, as amended. The reporting person exercised the warrant on a cashless basis pursuant to the terms of the warrant, resulting in the Company's withholding of 492,277 of the warrant shares to pay the exercise price and issuing to the reporting person the remaining 1,051,197 shares.
The warrants were issued to Taurus in March 2014 in connection with conversion of outstanding promissory notes and interest accrued thereon for units consisting of common stock and warrants.